Stocks
ICON Public Limited CompanyICLR
NASDAQHealthcareBiotechnology$98.33+0.90%
A global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, offering clinical research and commercialization solutions. Investors monitor ICON for its exposure to the growing contract research organization (CRO) market and its role in streamlining drug development processes.
Market Cap: $7.5B52W Range: $66.57 – $211.00
Congressional Interest in ICON Public Limited Company (ICLR)
8 members of Congress have disclosed 25 trades in ICON Public Limited Company (ICLR), a Healthcare company. The buy/sell breakdown shows 12 purchases versus 13 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
25
Unique Politicians
8
Buys
12
Sells
13
Who in Congress Is Trading ICLR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-05 | Kevin Hern | sell | $100K – $250K |
| 2026-02-12 | Julia Letlow | sell | $1K – $15K |